Kelly Rogers

Kelly joins the In Vitro Biology team at Atalanta after accumulating more than a decade of valuable drug discovery experience at Sanofi-Genzyme. During that time, Kelly’s research efforts extensively involved the development and implementation of molecular and biochemical assays to credential novel targets and therapeutic approaches for genetic kidney diseases. Prior to working in drug discovery, Kelly assisted with molecular genetic studies of centromere structure and function at the University of Massachusetts Medical School in Worcester, MA. Kelly received her B.A. in biology from Assumption College and then earned her M.S. in biotechnology from Worcester State College.